American Journal of Roentgenology, Vol 171, 449-454, Copyright © 1998 by American Roentgen Ray Society

ARTICLES

Sonographically guided microwave coagulation treatment of liver cancer: an experimental and clinical study

BW Dong, P Liang, XL Yu, XQ Zeng, PJ Wang, L Su, XD Wang, H Xin and S Li
Department of Ultrasound, Chinese PLA General Hospital, Beijing, People's Republic of China.

OBJECTIVE: Percutaneous microwave coagulation was performed with a modified system in animal experiments and in a clinical study to evaluate this technique as a treatment option for liver cancer. SUBJECTS AND METHODS: As an in vitro study, a microwave electrode was inserted 5-6 cm into separated egg white, homogenate of pig liver, and pig liver, with different power outputs and different lengths of inner conductors. In the animal experiment, the sonographically guided coagulation was performed percutaneously nine times and at laparotomy 43 times on 17 adult dogs. The thermal needles were placed parallel to and 5 mm, 8-12 mm, and 15 mm from the electrode. Clinically, 41 patients with hepatocellular carcinoma and 10 patients with hepatic metastases were treated with a 60-W microwave emission for 240-300 sec. RESULTS: Microwave coagulation using the modified system at 60 W for 300 sec produced a necrosis volume of 3.7 x 2.6 x 2.6 cm. The coagulated volume was elliptic when the exposed inner conductor of the electrode was 27 mm. The temperature at the periphery was 62.0 +/- 5.8 degrees C. During a mean follow-up period of 23 months, in 41 patients with hepatocellular carcinoma, 79% (46/58) of lesions became smaller, and the intratumoral blood flow disappeared in 89% (47/53). All tumors showed decreased density on unenhanced CT, and 84% (32/38) of tumors showed no enhancement on contrast-enhanced CT. In 21 patients with an elevated alpha-fetoprotein level, the level decreased in all 21 and was normalized in 17. A second biopsy on 19 patients showed complete destruction of tumor in 18. In 10 patients with hepatic metastases, the mean follow-up period was 13 months. Shrinkage of lesions occurred in 84% (21/25), and the blood flow inside the tumor disappeared in 75% (12/16) of lesions. Seventy-three percent (8/11) of the nodules showed no enhancement. A second biopsy on six patients showed complete necrosis in five. CONCLUSION: Sonographically guided microwave coagulation performed with this modified system was an effective and safe treatment for liver cancer.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. E. Clark, R. D. Woodruff, R. J. Zagoria, and M. C. Hall Microwave Ablation of Renal Parenchymal Tumors Before Nephrectomy: Phase I Study Am. J. Roentgenol., May 1, 2007; 188(5): 1212 - 1214. [Abstract] [Full Text] [PDF]

				E. Liapi and J.-F. H. Geschwind Transcatheter and Ablative Therapeutic Approaches for Solid Malignancies J. Clin. Oncol., March 10, 2007; 25(8): 978 - 986. [Abstract] [Full Text] [PDF]

				M. Kuang, M. D. Lu, X. Y. Xie, H. X. Xu, L. Q. Mo, G. J. Liu, Z. F. Xu, Y. L. Zheng, and J. Y. Liang Liver Cancer: Increased Microwave Delivery to Ablation Zone with Cooled-Shaft Antenna--Experimental and Clinical Studies Radiology, March 1, 2007; 242(3): 914 - 924. [Abstract] [Full Text] [PDF]

				P. Liang, B. Dong, X. Yu, D. Yu, Y. Wang, L. Feng, and Q. Xiao Prognostic Factors for Survival in Patients with Hepatocellular Carcinoma after Percutaneous Microwave Ablation Radiology, April 1, 2005; 235(1): 299 - 307. [Abstract] [Full Text] [PDF]

				P. Liang, B. Dong, X. Yu, Y. Yang, D. Yu, L. Su, Q. Xiao, and L. Sheng Prognostic Factors for Percutaneous Microwave Coagulation Therapy of Hepatic Metastases Am. J. Roentgenol., November 1, 2003; 181(5): 1319 - 1325. [Abstract] [Full Text] [PDF]

				B. Dong, P. Liang, X. Yu, L. Su, D. Yu, Z. Cheng, and J. Zhang Percutaneous Sonographically Guided Microwave Coagulation Therapy for Hepatocellular Carcinoma: Results in 234 Patients Am. J. Roentgenol., June 1, 2003; 180(6): 1547 - 1555. [Abstract] [Full Text] [PDF]

				M.-d. Lu, J.-w. Chen, X.-y. Xie, L. Liu, X.-q. Huang, L.-j. Liang, and J.-f. Huang Hepatocellular Carcinoma: US-guided Percutaneous Microwave Coagulation Therapy Radiology, October 1, 2001; 221(1): 167 - 172. [Abstract] [Full Text] [PDF]

				M. F. Meloni, S. N. Goldberg, T. Livraghi, F. Calliada, P. Ricci, M. Rossi, D. Pallavicini, and R. Campani Hepatocellular Carcinoma Treated with Radiofrequency Ablation: Comparison of Pulse Inversion Contrast-Enhanced Harmonic Sonography, Contrast-Enhanced Power Doppler Sonography, and Helical CT Am. J. Roentgenol., August 1, 2001; 177(2): 375 - 380. [Abstract] [Full Text] [PDF]

				G. D. Dodd III, M. C. Soulen, R. A. Kane, T. Livraghi, W. R. Lees, Y. Yamashita, A. R. Gillams, O. I. Karahan, and H. Rhim Minimally Invasive Treatment of Malignant Hepatic Tumors: At the Threshold of a Major Breakthrough RadioGraphics, January 1, 2000; 20(1): 9 - 27. [Abstract] [Full Text] [PDF]

				S. N. Goldberg, R. C. Walovitch, J. A. Straub, M. T. Shore, and G. S. Gazelle Radio-frequency-induced Coagulation Necrosis in Rabbits: Immediate Detection at US with a Synthetic Microsphere Contrast Agent Radiology, November 1, 1999; 213(2): 438 - 444. [Abstract] [Full Text]